Ross G.
Ross G. Bierbryer, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110264993 | Multi-Threaded Sort of Data Items in Spreadsheet Tables - To perform a sort operation on a spreadsheet table, data items in the spreadsheet table are divided into a plurality of blocks. Multiple threads are then used to sort the data items in the blocks. After the data items in the blocks are sorted, multiple threads are used to merge the blocks into a final block. The final block contains each of the data items in the spreadsheet table. A sorted version of the spreadsheet table is then displayed. Data items in the sorted version of the spreadsheet table have the same order as an order of data items in the final block. | 10-27-2011 |
Ross G. Cart, River Forest, IL US
Patent application number | Description | Published |
---|---|---|
20110092301 | CHILD SWING AND JUMPER APPARATUS AND METHODS OF OPERATING THE SAME - A child entertainment apparatus is convertible between a swing mode and a jumper mode. An example apparatus includes a frame, and a seat. The seat is coupled to the frame by a substantially rigid support when the apparatus is in the swing mode, and the seat is coupled to the frame through a substantially flexible support when the apparatus is in the jumper mode. | 04-21-2011 |
Ross G. Clark, Auckland NZ
Patent application number | Description | Published |
---|---|---|
20090011988 | METHOD FOR TREATING CARTILAGE DISORDERS - The present invention relates to a method for the treatment of a cartilage disorder, including cartilage damaged by injury or degenerative cartilagenous disorders. The method involves contacting the cartilage with an IGF-1 analog with altered affinity for IGF-binding proteins (IGFBPs) or an IGFBP displacer peptide that prevents the interaction of an IGF with an IGFBP and does not bind to a human IGF receptor. | 01-08-2009 |
20100130411 | METHOD FOR TREATING CARTILAGE DISORDERS - The present invention relates to a method for the treatment of a cartilage disorder, including cartilage damaged by injury or degenerative cartilagenous disorders. The method involves contacting the cartilage with an IGF-1 analog with altered affinity for IGF-binding proteins (IGFBPs) or an IGFBP displacer peptide that prevents the interaction of an IGF with an IGFBP and does not bind to a human IGF receptor. | 05-27-2010 |
20100137200 | METHODS FOR TREATMENT OF GROWTH DISORDERS - The present invention provides methods and compositions for increasing the growth rates, alleviating the symptoms, or improving the metabolism of human patients having an endocrine disorder characterized by partial endogenous growth hormone activity or signaling. The invention provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) effective to improve metabolism in the patient, where the patient receives IGF-1 in a single daily administration. The invention also provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) and an amount of growth hormone (GH) that in combination are effective to improve growth or metabolism in the patient, where the patient receives IGF-1 in a single daily administration and receives GH in a single daily administration, and where the single IGF-1 administration and the single GH ad-ministration are administered to the patient substantially contemporaneously each day. | 06-03-2010 |
Ross G. Clark, Devonport NZ
Patent application number | Description | Published |
---|---|---|
20090270323 | METHODS FOR TREATMENT OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY - The present invention provides methods and compositions for increasing the growth rates, alleviating the symptoms, or improving the metabolism of human patients having insulin-like growth factor-I deficiency (IGFD). The invention relates to methods comprising administering insulin-like growth factor-I to a patient having a height which, at the time of treatment or prior to initial treatment with IGF-1, is at least about 2 standard deviations below normal for a subject of the same age and gender, a blood level of insulin-like growth factor-I that, and at the time of treatment or prior to initial treatment with IGF-1, is below normal mean levels, usually at least about 1 standard deviations below normal mean levels, for age and gender. | 10-29-2009 |
20120232009 | Methods for Treatment of Insulin-Like Growth Factor-1 Deficiency - The present invention provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) and an amount of growth hormone (GH) that in combination are effective to improve growth or metabolism in the patient, where the patient receives IGF-1 in a single daily administration and receives GH in a single daily administration, and where the single administrations are administered to the patient substantially contemporaneously each day. | 09-13-2012 |